| Literature DB >> 29090617 |
Wataru Tsukimura1, Masaki Kurogochi2, Masako Mori1, Kenji Osumi2, Akio Matsuda1,2, Kaoru Takegawa3, Kiyoshi Furukawa1, Takashi Shirai1,2.
Abstract
Recently, the absence of a core-fucose residue in the N-glycan has been implicated to be important for enhancing antibody-dependent cellular cytotoxicity (ADCC) activity of immunoglobulin G monoclonal antibodies (mAbs). Here, we first prepared anti-HER2 mAbs having two core-fucosylated N-glycan chains with the single G2F, G1aF, G1bF, or G0F structure, together with those having two N-glycan chains with a single non-core-fucosylated corresponding structure for comparison, and determined their biological activities. Dissociation constants of mAbs with core-fucosylated N-glycans bound to recombinant Fcγ-receptor type IIIa variant were 10 times higher than those with the non-core-fucosylated N-glycans, regardless of core glycan structures. mAbs with the core-fucosylated N-glycans had markedly reduced ADCC activities, while those with the non-core-fucosylated N-glycans had high activities. These results indicate that the presence of a core-fucose residue in the N-glycan suppresses the binding to the Fc-receptor and the induction of ADCC of anti-HER2 mAbs.Entities:
Keywords: ADCC activity; N-glycans; core-fucosylation; monoclonal antibodies; therapeutic potential
Mesh:
Substances:
Year: 2017 PMID: 29090617 DOI: 10.1080/09168451.2017.1394813
Source DB: PubMed Journal: Biosci Biotechnol Biochem ISSN: 0916-8451 Impact factor: 2.043